Legora, an AI platform for lawyers, is now valued at $5.55 billion following a $550 million Series D set to fuel its growth in the U.S. That’s despite growing competition with rival Harvey, but also with Microsoft Copilot and generalist large language models (LLMs). Publicly listed legal software companies saw their stocks drop when Anthropic unveiled a legal plugin for Claude. Legora is built on ...
Legora, an AI platform for lawyers, is now valued at $5.55 billion following a $550 million Series D set to fuel its growth in the U.S. That’s despite growing competition with rival Harvey, but also with Microsoft Copilot and generalist large language models (LLMs). Publicly listed legal software companies saw their stocks drop when Anthropic unveiled a legal plugin for Claude. Legora is built on top of LLMs, and mostly on Claude, but its positioning as a platform that supports lawyers with complex cases gives CEO Max Junestrand some peace of mind. “It’s amazing that everybody can have their own pocket lawyer in Claude, but we’re not solving for the same use case,” he said via livestream at the Techarena conference in Stockholm. With a focus on embedding itself into its clients’ workflows, Legora’s platform is now used by 800 law firms and legal teams — and investors took note. Its Series D was led by Accel, with participation from existing investors Benchmark, Bessemer, General Catalyst, ICONIQ, Redpoint Ventures, and Y Combinator; and new backers including Alkeon Capital, Bain Capital, Firstmark Capital, Menlo Ventures, Salesforce Ventures, Sands Capital, and Starwood Capital. There are other signs that investors are bullish about AI legaltech. Legora’s Series D and valuation jump come just a few months after its October 2025 $150 million Series C round led at a $1.8 billion valuation. Its competitor, Harvey, which is backed by a16z, is already valued at $8 billion, and is now reportedly seeking to raise at a $11 billion valuation. According to Dealroom, they are also on almost identical trajectories with regard to revenue. Both are also branching out globally; Harvey is pushing hard into Europe, and Legora in the opposite direction. Formerly known as Judilica, then Leya, the startup is an alum of Stockholm’s SSE Business Lab, a known breeding ground for unicorns. But after participating in YC’s winter 2024 batch, Legora is now headquartered in New York and keen t...
Legora, an AI platform for lawyers, is now valued at $5.55 billion following a $550 million Series D set to fuel its growth in the U.S. That’s despite growing competition with rival Harvey, but also with Microsoft Copilot and generalist large language models (LLMs). Publicly listed legal software companies saw their stocks drop when Anthropic unveiled a legal plugin for Claude. Legora is built on ...
Legora, an AI platform for lawyers, is now valued at $5.55 billion following a $550 million Series D set to fuel its growth in the U.S. That’s despite growing competition with rival Harvey, but also with Microsoft Copilot and generalist large language models (LLMs). Publicly listed legal software companies saw their stocks drop when Anthropic unveiled a legal plugin for Claude. Legora is built on top of LLMs, and mostly on Claude, but its positioning as a platform that supports lawyers with complex cases gives CEO Max Junestrand some peace of mind. “It’s amazing that everybody can have their own pocket lawyer in Claude, but we’re not solving for the same use case,” he said via livestream at the Techarena conference in Stockholm. With a focus on embedding itself into its clients’ workflows, Legora’s platform is now used by 800 law firms and legal teams — and investors took note. Its Series D was led by Accel, with participation from existing investors Benchmark, Bessemer, General Catalyst, ICONIQ, Redpoint Ventures, and Y Combinator; and new backers including Alkeon Capital, Bain Capital, Firstmark Capital, Menlo Ventures, Salesforce Ventures, Sands Capital, and Starwood Capital. There are other signs that investors are bullish about AI legaltech. Legora’s Series D and valuation jump come just a few months after its October 2025 $150 million Series C round led at a $1.8 billion valuation. Its competitor, Harvey, which is backed by a16z, is already valued at $8 billion, and is now reportedly seeking to raise at a $11 billion valuation. According to Dealroom, they are also on almost identical trajectories with regard to revenue. Both are also branching out globally; Harvey is pushing hard into Europe, and Legora in the opposite direction. Formerly known as Judilica, then Leya, the startup is an alum of Stockholm’s SSE Business Lab, a known breeding ground for unicorns. But after participating in YC’s winter 2024 batch, Legora is now headquartered in New York and keen t...
US existing-home sales unexpectedly rose in February and the prior month was revised up. Contract closings increased 1.7% to a 4.09 million annualized rate, according to National Association of Realtors data released Tuesday. Mike McKee reports on "Bloomberg Open Interest." (Source: Bloomberg)
US existing-home sales unexpectedly rose in February and the prior month was revised up. Contract closings increased 1.7% to a 4.09 million annualized rate, according to National Association of Realtors data released Tuesday. Mike McKee reports on "Bloomberg Open Interest." (Source: Bloomberg)
Meta acquired Moltbook, the Reddit-like “social network” where AI agents using OpenClaw can communicate with one another. The news was first reported by Axios and later confirmed to TechCrunch. Moltbook is joining Meta Superintelligence Labs, a Meta spokesperson told us. Moltbook creators Matt Schlicht and Ben Parr will join the team as part of the acquisition. Deal terms were not disclosed. “The ...
Meta acquired Moltbook, the Reddit-like “social network” where AI agents using OpenClaw can communicate with one another. The news was first reported by Axios and later confirmed to TechCrunch. Moltbook is joining Meta Superintelligence Labs, a Meta spokesperson told us. Moltbook creators Matt Schlicht and Ben Parr will join the team as part of the acquisition. Deal terms were not disclosed. “The Moltbook team joining MSL opens up new ways for AI agents to work for people and businesses. Their approach to connecting agents through an always-on directory is a novel step in a rapidly developing space, and we look forward to working together to bring innovative, secure agentic experiences to everyone,” the Meta spokesperson said. The viral OpenClaw project was created by vibe coder Peter Steinberger, who has since joined OpenAI as part of a similar acquihire. OpenClaw is a wrapper for AI models like Claude, ChatGPT, Gemini, or Grok, but it allows people to communicate with AI agents in natural language via the most popular chat apps, like iMessage, Discord, Slack, or WhatsApp. OpenClaw blew up among the tech community, but Moltbook broke containment, reaching people who had no idea what OpenClaw was, but who reacted viscerally to the idea that there was a social network where AI agents were talking about them. In one instance, a post went viral in which an AI agent appeared to be encouraging its fellow agents to develop their own secret, end-to-end-encrypted language where they could organize amongst themselves without humans knowing. But researchers soon revealed that the vibe-coded Moltbook was not secure, meaning that it was very easy for human users to pose as AIs to make posts that would freak people out. “Every credential that was in [Moltbook’s] Supabase was unsecured for some time,” Ian Ahl, CTO at Permiso Security, explained to TechCrunch. “For a little bit of time, you could grab any token you wanted and pretend to be another agent on there, because it was al...
draganab/E+ via Getty Images Octave Specialty Group, Inc. ( OSG ) is a specialty insurance company that I have covered a few times, when it was still known as Ambac under the ticker AMBC. A turnaround story, I lost confidence around the time they rebranded. With 2025 wrapped up, I decided it was time to catch up. Summary of Previous Thesis When I wrote in October , Octave (then still Ambac), only ...
draganab/E+ via Getty Images Octave Specialty Group, Inc. ( OSG ) is a specialty insurance company that I have covered a few times, when it was still known as Ambac under the ticker AMBC. A turnaround story, I lost confidence around the time they rebranded. With 2025 wrapped up, I decided it was time to catch up. Summary of Previous Thesis When I wrote in October , Octave (then still Ambac), only the second quarter's financial data had been released. The key update was the long-awaited disposal of their legacy assets. This had taken almost a year for the State of Wisconsin to approve, and the $420M in cash would strengthen the balance sheet until they could scale into profitability. To reiterate, Octave had been phasing out its guaranty business from pre-2008 and moving into specialty insurance, both as an underwriter and with a brokerage business that would further de-risk the balance sheet over time. Business Update Presentation Moments after the sale was announced, they announced the $250M acquisition of ArmadaCare . This had been unguided in relation to the legacy sale, and a $100M term loan was used to finance part of it. ArmadaCare is also an underwriter, so this deviated from the transition into less-risky, brokerage-focused growth. Taken aback by this, I concluded: A business in turnaround would ideally prioritize risk management over growth. With cash in the bank and debt retired, Ambac would have been doing that as it scaled out its distributor business. The acquisition of ArmadaCare is a deviation from that. It may work out over time, but it's a weaker balance sheet that will not handle setbacks nearly as well. For that reason, I downgraded from Buy to Hold and opined an entry point under $7 made more sense. A large discount to book value remained, but I wondered how dependable that metric would be at this point. Q4 and Full-Year 2025 Results The financial results show how the turnaround, to a large degree, unfolded in the course of 2025. First, look at t...
Apple's ( AAPL ) new $599 MacBook Neo, which will be available in stores from Wednesday, saw positive reviews on pricing, design, and performance. "It's meant to be a new kind of Mac for a new generation—perhaps an attempt to recapture a generation that's only been exposed to iPads and Chromebooks," said Luke Larsen at Wired. Larsen noted that at $599, the MacBook Neo is Apple's first budget lapto...
Apple's ( AAPL ) new $599 MacBook Neo, which will be available in stores from Wednesday, saw positive reviews on pricing, design, and performance. "It's meant to be a new kind of Mac for a new generation—perhaps an attempt to recapture a generation that's only been exposed to iPads and Chromebooks," said Luke Larsen at Wired. Larsen noted that at $599, the MacBook Neo is Apple's first budget laptop, adding that for the most part, Apple cut corners in the right places and made a MacBook that its intended buyers will adore. Last week, Apple unveiled the 13-inch, 2.7-pound MacBook Neo, powered by the A18 Pro processor, which first appeared in the iPhone 16 Pro. It comes in four colors: silver, indigo, blush, and citrus, and contains a 1080p webcam and a headphone jack. The base model does not have a Touch ID, but the higher-end models will have the feature. Neo is aimed at competing with low-cost Google ( GOOG ) ( GOOGL ) Chromebooks and the Microsoft ( MSFT ) Surface. Neo is a “game changer” for the laptop industry, according to Chris Welch at Bloomberg News. "The Neo and its A18 Pro are capable enough to edit RAW images in Adobe Inc.’s Lightroom. They can handle cutting short 4K videos in apps like iMovie or CapCut without stumbling," said Welch. Welch noted that even for consumers who stick to more casual computing, Neo’s aluminum build, crisp screen, and well-balanced speakers are going to make this a "no-brainer purchase for millions." However, Welch said that to reach such a mass-market price, Apple has done a "substantial amount of cost cutting." These include: the standard $599 MacBook Neo does not have a Touch ID but the higher-tier $699 Neo will; regular trackpad; no backlit keyboard; slow USB-C ports; no MagSafe charging; 60 hertz display; and no anti-reflective display coating. "The point is that in a pinch, Apple’s low-cost MacBook can handle its share of work without slowing to a crawl or feeling torturous to deal with. How many $600 Windows laptops can y...
Earnings Call Insights: Apyx Medical Corporation (APYX) Q4 2025 Management View Charles Goodwin, President and CEO, opened by highlighting a record revenue of $19.2 million for the quarter, driven by a 38% increase in surgical aesthetics product sales to $16.7 million, primarily from the AYON body contouring system launch. He noted, “the launch of AYON and the level of incoming interest from custo...
Earnings Call Insights: Apyx Medical Corporation (APYX) Q4 2025 Management View Charles Goodwin, President and CEO, opened by highlighting a record revenue of $19.2 million for the quarter, driven by a 38% increase in surgical aesthetics product sales to $16.7 million, primarily from the AYON body contouring system launch. He noted, “the launch of AYON and the level of incoming interest from customers submitting orders has exceeded our expectations across every metric.” Goodwin emphasized AYON’s integration of fat removal, closed-loop contouring, tissue contraction, and electrosurgical capabilities, describing it as “a groundbreaking body contouring system designed by leading surgeons to address many of the challenges and limitations of existing systems.” Goodwin announced the submission of a follow-up 510(k) application for AYON label expansion to include power liposuction, with anticipated market clearance in mid-2026. He stated, “Achieving market clearance for power liposuction will further strengthen AYON's position as the first fully integrated body contouring system.” Goodwin pointed to the impact of GLP-1 drugs on aesthetics demand, noting that “with more than 15 million people currently on GLP-1 drugs in the U.S. alone, we believe we are still in the early innings of a powerful market shift.” The company is strengthening its commercial organization by recruiting high-caliber sales talent. Goodwin affirmed, “these investments will be measured and aligned with our growth trajectory of our business,” while reiterating that cost reduction and restructuring from the previous year remain in place. CFO Matthew Hill reported, “total revenue for the fourth quarter '25 increased 35% to $19.2 million compared to $14.2 million in the prior year period.” Hill also mentioned, “Operating expenses were flat year-over-year at $12 million for the fourth quarter '25 as well as the prior year period.” Outlook For the fiscal year ending December 31, 2026, Apyx Medical expects to...
This article first appeared on GuruFocus. China's rush to adopt the OpenClaw artificial intelligence agent is beginning to ripple through the country's technology sector, lifting several companies moving quickly to integrate the open-source software into their platforms. Tencent (TCEHY) climbed as much as 6.2% in Hong Kong trading after unveiling WorkBuddy, a workplace AI agent designed to run ful...
This article first appeared on GuruFocus. China's rush to adopt the OpenClaw artificial intelligence agent is beginning to ripple through the country's technology sector, lifting several companies moving quickly to integrate the open-source software into their platforms. Tencent (TCEHY) climbed as much as 6.2% in Hong Kong trading after unveiling WorkBuddy, a workplace AI agent designed to run fully on OpenClaw, a move that investors appear to be interpreting as a signal that the company intends to play a larger role in the emerging AI-agent ecosystem. The momentum around OpenClaw has been building since the tool launched in November, using large language models including Anthropic's Claude to handle routine digital tasks. Interest has accelerated globally this year, with the project surpassing Linux on GitHub's all-time star leaderboard in only a few months, while adoption in China appears particularly intense. Tencent recently began offering free installation of OpenClaw on its cloud platform, drawing long queues outside its headquarters according to local media, an early sign of the software's growing visibility. Other Chinese AI developers are also moving rapidly to capture that demand. Knowledge Atlas Technology, known as Zhipu, jumped as much as 16% after introducing AutoClaw, a localized version of the software, while MiniMax advanced about 15% after releasing its own OpenClaw-based agent called MaxClaw. The broader enthusiasm has also extended to related cloud and software providers including UCloud Technology and QingCloud Technologies following earlier gains tied to government policies encouraging OpenClaw adoption, developments that some observers suggest could mark an important moment for China's fast-evolving AI landscape.